Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRT-201 in CKD patients undergoing AVG creation
NCT01001351Phase 2Completed
- Sponsor
- Proteon Therapeutics
- Start
- Sep 2009
- Primary completion
- Nov 2012
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of vonapanitase in chronic kidney disease (CKD), sponsored by Proteon Therapeutics. Started Sep 2009; status: completed.
02
Drugs
vonapanitase
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT01001351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01001351.